Not to make light of your troubles or state an
Not to make light of your troubles or state an oversimplification:
This virus is not dead. It is not like polio or other pandemics that have been eradicated for all intents and purposes. It is impossible to even predict the course of the vaccine, let alone that of the virus itself.
Long-hauler symptoms aside (and these shouldn't be taken lightly), there are multiple variants of symptoms from person to person. The variants of the virus are well-documented, but how one responds to the vaccine and/or the virus is unpredictable.
Case in point: My wife was the last one in the family to get the vaccine because she has so many allergies, and she was afraid of an adverse reaction. She couldn't take the PFE vaccine because she must carry an EPI pen. She finally consented to get the mRNA vaccine. Like most of us she breezed through the first dose. After the second dose, I was down a couple days; mild fever and extreme fatigue. However, she barely reacted to the second dose, EPI pen in hand.
This is why the "complete vaccine" is so essential. I still don't know if he we have the real thing or not. I'm not even sure of what it will take for the FDA or FDA's around the world to acknowledge that NGIO has the complete vaccine. Secondly, for us holders of CYDY, there is no reliable therapeutic that one can take if they do sick. There are few common denominators in the vaccine and the virus. Research has to focus on those common denominators so that non-vaxers and patients alike can have confidence in the available modalities without panicking or having to be treated on an emergency basis. Does that make sense to you guys?
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Crafting Memories over Clicking Screens The holidays are supposed to be about making memories, right? Well, Michaels is banking on that idea by pulling people away from their screens and nudging them into a hands-on world with its "Countdown to Craftsmas" advent calendar. Starting November 27, they’re tossing in a freebie that’s packing some crafty punches — just...
Continue Reading
PIMJETMI® Scores FDA Approval, Expanding Global Reach Well, here's something to chew on over your morning coffee—PIMJETMI® (pimicotinib) just snagged the U.S. FDA's blessing to treat tenosynovial giant cell tumor (TGCT), making it another notch on Abbisko Therapeutics' belt. This approval is a strategic home run for Abbisko and their pals at Merck KGaA, Darmstadt,...
Continue Reading
A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...
Continue Reading
These days, digital marketing feels like trying to build a puzzle in a sandstorm. You've got all these pieces flying around, valuable insights buried somewhere in the mix, and you can't just toss 'em together however you like. Supermetrics steps into this whirlwind with their new tool, Campaign Manager, promising marketers a direct line from insight to action. Finally, a...
Continue Reading
Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...
Continue Reading
Fine-tuning in the Wild West of Copy Trading Pull up a chair, because this is one for the books. Bybit, that sprawling new financial playground trusted by 80 million folks around the globe, just laid another stone on the path to trading enlightenment with their Copy Trading Classic. They’ve cranked up the ability to sift through Master Traders like a prospector panning...
Continue Reading
Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...
Continue Reading
Reworking the Debt Load: Braemar's New Move Most days, when a company decides to tinker with its debt, it's like watching paint dry for investors. But with Braemar Hotels & Resorts (NYSE: BHR) announcing a $358 million refinancing package, they're bringing a fresh breath of air to the table. Lemme walk you through why this matters beyond the glossy façade of luxury hotel...
Continue Reading
Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...
Continue Reading
AI's Lofty Goals Meet Retail's Messy Reality I swear, all this chatter about AI transforming retail sounds grand until you dig into the messy trenches, right? This latest Scandit survey lays it bare: retailers have got their AI visions sprinting ahead of the stock data realities inside their stores. Seems those shiny new systems rely on stock data that matches what's...
Continue Reading
Top 5 Most Recently Viewed Articles
Foresight's Recent Nasdaq Compliance Notification Ness Ziona, Israel — Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX), recognized for its pioneering work in 3D perception systems, has received important news regarding its standing on the Nasdaq Stock Market. Recently, the company was notified that it is currently not in compliance with Nasdaq Listing Rule 5550(a)(2)...
Continue Reading
Waters Corporation's Sustainability Achievement Waters Corporation (NYSE: WAT) has proudly announced its inclusion in the Dow Jones Sustainability North America Index for the fourth consecutive year. This recognition reflects the company's unwavering commitment to sustainable practices across its operations. The Dow Jones Sustainability Index, recognized globally,...
Continue Reading
U.S. News Reveals the Best Bed & Breakfasts for 2025 More than 350 exceptional bed-and-breakfasts, inns, and small hotels have been celebrated in the latest U.S. News rankings. These offerings span 17 diverse U.S. destinations, representing the richness and charm of local hospitality. Recognizing Excellence in Hospitality The 2025 Best Bed & Breakfasts rankings shine a...
Continue Reading
Stanley Druckenmiller opened up about his past Nvidia investment and let me tell ya, it’s a classic case of a pro getting schooled. Back when shares were swinging between $800 and $950, he made the call to sell. Now? The stock’s been on a tear, landing at around $139.59. I mean, talk about leaving money on the table—he's feeling that sting hard. Druckenmiller’s...
Continue Reading
Teamsters Union's Choice on 2024 Presidential Endorsements The Teamsters union, recognized as a powerful voice in the labor community, has recently made a significant announcement concerning the upcoming 2024 presidential elections. In a statement issued by their executive board, the union revealed that it will not endorse any presidential candidate this year. This...
Continue Reading